" /> mFOLFOX6-Bevacizumab Regimen - CISMeF





Preferred Label : mFOLFOX6-Bevacizumab Regimen;

NCIt synonyms : mFOLFOX6/Bevacizumab; mFOLFOX6-Bevacizumab; mFOLFOX6 Plus Bevacizumab; mFOLFOX6-Avastin; Bevacizumab Plus mFOLFOX6; Modified FOLFOX6-Bevacizumab; Bevacizumab-mFOLFOX6;

NCIt related terms : mFOLFOX6-B; mFOLFOX6-B (bevacizumab-bvzr); mFOLFOX6-B (bevacizumab-adcd); mFOLFOX6-B (bevacizumab-equi); mFOLFOX6-B (bevacizumab-onbe); mFOLFOX6-B (bevacizumab-awwb); mFOLFOX6-B (bevacizumab-maly); mFOLFOX6-B (bevacizumab-aybi); mFOLFOX6-B (L-Leucovorin) (bevacizumab-tnjn); mFOLFOX6-B (bevacizumab-tnjn);

NCIt definition : A regimen consisting of bevacizumab and a modified version of the FOLFOX6 regimen (mFOLFOX6), which contains leucovorin, infusional fluorouracil and oxaliplatin, that may be used for the treatment of ampullary and appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma.;

NCI Metathesaurus CUI : CL1905363;

Codes from synonyms : 14783; 127245; 127467; 127541; 127319; 127615; 127171; 127393; 144033; 144032;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.